La dernière actualité médicale WillebrandXPERT
Consultez la version en ligne
WillebrandXPERT
Chère consœur, cher confrère,
Retrouvez ci-après les dernières publications scientifiques issues de revues à comité de lecture dans votre domaine d'expertise.
Von Willebrand Academy - Ep.4
Publications du  Samedi 14 février 2026
Individualizing dosing frequency may improve the efficacy of prophylaxis in patients with von Willebrand disease—a WIL-31 subanalysis
Research and Practice in Thrombosis and Haemostasis 2025; 9(7): 103221
The efficacy and safety of prophylaxis with wilate, a plasma-derived von Willebrand factor/factor VIII concentrate, was demonstrated in patients with von Willebrand disease of all types in the WIL-31 study....
En savoir plus |  Version PDF  |  Imprimer l'abstract
A bispecific nanobody for the treatment of von Willebrand disease type 1
Blood 2025; 146(21): 2597-607
von Willebrand disease (VWD) type 1 is a bleeding disorder characterized by a quantitative deficiency of functional von Willebrand factor (VWF). We designed a novel bispecific nanobody, named KB-V13A12,...
En savoir plus |  Version PDF  |  Imprimer l'abstract
Outcomes and Healthcare Resource Utilisation in Adults With von Willebrand Disease Receiving On-Demand Recombinant von Willebrand Factor in the United Kingdom
European Journal Of Haematology. Volume 116(1).
We describe treatment outcomes and healthcare resource utilisation (HCRU) in adults with von Willebrand disease (VWD) treated on demand with recombinant von Willebrand factor (rVWF) in the United Kingdom. Methods:...
En savoir plus |  Version PDF  |  Imprimer l'abstract
Novel therapies for von Willebrand disease
Blood advances 2026; 10(15): 5253-63
For the past decades, treatment for von Willebrand disease has essentially consisted of classic approaches, and only in the past few years has the need for more innovative strategies been recognized. To...
En savoir plus |  Version PDF  |  Imprimer l'abstract
Accueil  |  Actualités  |  Archives
Informer un confrère | Modifier votre profil | Se désinscrire | Sources et critères
GNM Healthcare